Reprieve Cardiovascular is a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF). The company's Reprieve technology is being investigated as an innovative fluid management therapy. Providing clinicians with the ability to precisely control a patient's fluid volume may both enable improved cardiac care, as well as, be instrumental in the decongestion of ADHF patients. Reprieve Cardiovascular is led by a seasoned management team with extensive experience in the medical device industry.